From: Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients
Lehmann et al. discovery set (N = 386)
Lehmann et al. validation set (N = 201)
BL1
0.07
0.14
BL2
0.06
LAR
0.02
0.12
M
0.09
0.17
MSL
0.04
0.10